Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

48.17
-1.1800-2.39%
Post-market: 48.200.0300+0.06%19:56 EDT
Volume:5.85M
Turnover:284.22M
Market Cap:97.43B
PE:15.40
High:49.05
Open:48.93
Low:48.17
Close:49.35
52wk High:61.70
52wk Low:42.85
Shares:2.02B
Float Shares:1.94B
Volume Ratio:1.87
T/O Rate:0.30%
Dividend:1.80
Dividend Rate:3.74%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.17
PE(LYR):12.89

Loading ...

GSK's New Drug Launches Will be Key to 2027 Outlook

Dow Jones
·
Aug 04

Deutsche Bank Keeps Their Hold Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Aug 04

GlaxoSmithKline (GSK) Receives a Sell from Barclays

TIPRANKS
·
Aug 04

TD Cowen Keeps Their Hold Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Aug 03

Bernstein Sticks to Their Buy Rating for GlaxoSmithKline (GSK)

TIPRANKS
·
Aug 03

GSK price target raised to 2,000 GBp from 1,950 GBp at Deutsche Bank

TIPRANKS
·
Jul 31

GSK Advances New Toddler Pneumococcal Booster, Signaling Ongoing Vaccine Pipeline Momentum

TIPRANKS
·
Jul 31

GSK Slips Thursday, Underperforms Market

Dow Jones
·
Jul 31

GSK Supply Chain President Registers Sale of Ordinary Shares

TIPRANKS
·
Jul 30

GSK's ViiV Healthcare Highlights New Long-Acting Injectable Data on Cabenuva in HIV Treatment

MT Newswires Live
·
Jul 29

Cabenuva demonstrates superiority to daily oral therapy in adolescents with HIV

TIPRANKS
·
Jul 29

GSK: Hold Rating Reaffirmed as Near-Term Strength Offsets Long-Term Uncertainties; 2,350p Price Target Maintained

TIPRANKS
·
Jul 29

GSK Races To Protect Profits Before Its HIV Blockbuster Faces Generic Rivals

Benzinga Earnings
·
Jul 29

GSK Rises Tuesday, Outperforms Market

Dow Jones
·
Jul 29

GSK Licensor's Late-Stage China Study for Risvutatug Rezetecan in Bone Cancer Meets Primary Endpoint

MT Newswires Live
·
Jul 28

Bernstein Reaffirms Their Buy Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Jul 28

GSK Heading in Right Direction, but Investors Might Stay on Sidelines

Dow Jones
·
Jul 28

GSK Launches Cost-Saving Plan to Accelerate Drug Pipeline

Dow Jones
·
Jul 28

Stock Track | GSK Soars 5.31% in Pre-Market on Strong Q2 Earnings Beat and Positive Oncology Pipeline Updates

Stock Track
·
Jul 28

Movement Alert|GlaxoSmithKline PLC Rises 4.44% in Regular Trading, Q2 Revenue and Earnings Both Beat Expectations with Cost Savings Target Boosting Confidence

Market Focus
·
Jul 28